Surgery Partners, Inc. (SGRY) stock
SGRYNasdaqServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/3021% above fair value
$26.69−0.27 (-1.00%)
Close on Nov 19, 2026Market cap $3.49BP/E –Yield –
Surgery Partners free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Surgery Partners's free cash flow for the twelve months ending Jun 30, 2026 was $187.60M, up 7.0% year over year. For fiscal 2025 it was $195.60M, down 6.7% from the year before. Over ten years it grew 30.0% a year on average. The highest annual figure on record is $209.70M in fiscal 2024.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $195.60M | -6.7% |
| FY2024 | Dec 31, 2024 | $209.70M | +2.3% |
| FY2023 | Dec 31, 2023 | $205.00M | +162.1% |
| FY2022 | Dec 31, 2022 | $78.20M | +165.1% |
| FY2021 | Dec 31, 2021 | $29.50M | -85.5% |
| FY2020 | Dec 31, 2020 | $204.00M | +264.9% |
| FY2019 | Dec 31, 2019 | $55.90M | -46.7% |
| FY2018 | Dec 31, 2018 | $104.80M | +21.7% |
| FY2016 | Dec 31, 2016 | $86.13M | +68.7% |
| FY2015 | Dec 31, 2015 | $51.04M | +259.1% |
| FY2014 | Dec 31, 2014 | $14.21M | -68.4% |
| FY2013 | Dec 31, 2013 | $44.93M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $37.50M | -35.2% |
| Q1 FY2026 | Mar 31, 2026 | -$4.30M | – |
| Q4 FY2025 | Dec 31, 2025 | $90.60M | +1.7% |
| Q3 FY2025 | Sep 30, 2025 | $63.80M | +41.8% |
| Q2 FY2025 | Jun 30, 2025 | $57.90M | +3.6% |
| Q1 FY2025 | Mar 31, 2025 | -$16.70M | -184.8% |
| Q4 FY2024 | Dec 31, 2024 | $89.10M | +108.2% |
| Q3 FY2024 | Sep 30, 2024 | $45.00M | -47.5% |
| Q2 FY2024 | Jun 30, 2024 | $55.90M | +112.5% |
| Q1 FY2024 | Mar 31, 2024 | $19.70M | -60.8% |
| Q4 FY2023 | Dec 31, 2023 | $42.80M | – |
| Q3 FY2023 | Sep 30, 2023 | $85.70M | +591.1% |
| Q2 FY2023 | Jun 30, 2023 | $26.30M | +33.5% |
| Q1 FY2023 | Mar 31, 2023 | $50.20M | -18.5% |
| Q4 FY2022 | Dec 31, 2022 | -$15.50M | -376.8% |
| Q3 FY2022 | Sep 30, 2022 | $12.40M | – |
| Q2 FY2022 | Jun 30, 2022 | $19.70M | – |
| Q1 FY2022 | Mar 31, 2022 | $61.60M | +72.5% |
| Q4 FY2021 | Dec 31, 2021 | $5.60M | – |
| Q3 FY2021 | Sep 30, 2021 | -$600.00K | -103.2% |
| Q2 FY2021 | Jun 30, 2021 | -$11.20M | -106.4% |
| Q1 FY2021 | Mar 31, 2021 | $35.70M | +105.2% |
| Q4 FY2020 | Dec 31, 2020 | -$6.20M | -410.0% |
| Q3 FY2020 | Sep 30, 2020 | $19.00M | -50.6% |
| Q2 FY2020 | Jun 30, 2020 | $173.80M | +2494.0% |
| Q1 FY2020 | Mar 31, 2020 | $17.40M | +100.0% |
| Q4 FY2019 | Dec 31, 2019 | $2.00M | -93.8% |
| Q3 FY2019 | Sep 30, 2019 | $38.50M | +104.8% |
| Q2 FY2019 | Jun 30, 2019 | $6.70M | -80.1% |
| Q1 FY2019 | Mar 31, 2019 | $8.70M | -56.5% |
| Q4 FY2018 | Dec 31, 2018 | $32.30M | +151.4% |
| Q3 FY2018 | Sep 30, 2018 | $18.80M | -34.1% |
| Q2 FY2018 | Jun 30, 2018 | $33.70M | +55.7% |
| Q1 FY2018 | Mar 31, 2018 | $20.00M | +85.2% |
| Q2 FY2017 | Jun 30, 2017 | $12.85M | – |
| Q1 FY2017 | Mar 31, 2017 | $28.52M | – |
| Q4 FY2016 | Dec 31, 2016 | $21.64M | – |
| Q3 FY2016 | Sep 30, 2016 | $10.80M | – |
See a number that looks wrong?